Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ikeguchi

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
International Journal of Molecular Medicine|November 17, 2001
Changes in survivin messenger RNA level during cisplatin treatment in gastric cancerM Ikeguchi, N Kaibara
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 5, 1998
[Telomerase activity in esophageal squamous cell carcinoma and in normal esophageal epithelium adjacent to carcinoma]M Ikeguchi, N Kaibara
British Journal of Cancer|October 10, 2002
survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinomaM Ikeguchi, N Kaibara
Advances in Biophysics|January 1, 1994
Conformational comparison between alpha-lactalbumin and lysozymeS Sugai, M Ikeguchi
International Journal of Peptide and Protein Research|April 1, 1989
Contribution of disulfide bonds to stability of the folding intermediate of alpha-lactalbuminM Ikeguchi, S Sugai
International Journal of Cancer|October 31, 2000
Cisplatin combined with prostaglandin E1 chemotherapy in rat peritoneal carcinomatosisM Ikeguchi, M Maeta, N Kaibara
Langenbeck'S Archives of Surgery|December 29, 2000
Limited operation for patients with T1 esophageal cancerM Ikeguchi, M Maeta, N Kaibara
Apoptosis : an International Journal on Programmed Cell Death|January 5, 2002
Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatmentM Ikeguchi, J Liu, N Kaibara
Surgery Today|January 1, 1993
Patients with multiple primary gastric cancers tend to develop second primaries in organs other than the stomachN Kaibara, M Maeta, M Ikeguchi
Anticancer Research|March 28, 2001
Telomerase activity and p53 gene mutation in familial polyposis coliM Ikeguchi, M Makino, N Kaibara
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
International Journal of Molecular Medicine|November 17, 2001
Changes in survivin messenger RNA level during cisplatin treatment in gastric cancerM Ikeguchi, N Kaibara
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 5, 1998
[Telomerase activity in esophageal squamous cell carcinoma and in normal esophageal epithelium adjacent to carcinoma]M Ikeguchi, N Kaibara
British Journal of Cancer|October 10, 2002
survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinomaM Ikeguchi, N Kaibara
Advances in Biophysics|January 1, 1994
Conformational comparison between alpha-lactalbumin and lysozymeS Sugai, M Ikeguchi
International Journal of Peptide and Protein Research|April 1, 1989
Contribution of disulfide bonds to stability of the folding intermediate of alpha-lactalbuminM Ikeguchi, S Sugai
International Journal of Cancer|October 31, 2000
Cisplatin combined with prostaglandin E1 chemotherapy in rat peritoneal carcinomatosisM Ikeguchi, M Maeta, N Kaibara
Langenbeck'S Archives of Surgery|December 29, 2000
Limited operation for patients with T1 esophageal cancerM Ikeguchi, M Maeta, N Kaibara
Apoptosis : an International Journal on Programmed Cell Death|January 5, 2002
Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatmentM Ikeguchi, J Liu, N Kaibara
Surgery Today|January 1, 1993
Patients with multiple primary gastric cancers tend to develop second primaries in organs other than the stomachN Kaibara, M Maeta, M Ikeguchi
Anticancer Research|March 28, 2001
Telomerase activity and p53 gene mutation in familial polyposis coliM Ikeguchi, M Makino, N Kaibara
Pageof 15